Carvedilol Post-intervention Long-term Administration in Large-scale Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 801 participants.
Also called NCT01155635
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 801 participants
- Sponsor
- Registry
-
NCT01155635
-
- Other papers using this trial's data
- Effects of Long-Term Carvedilol Therapy in Patients With ST-Segment Elevation Myocardial Infarction and Mildly Reduced Left Ventricular Ejection Fraction
- Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01155635. Randomized; single masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2015-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Carvedilol Post-intervention Long-term Administration in Large-scale Trial
- Acronym
- CAPITAL-RCT
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Carvedilol
- Intervention (Drug)
- No Carvedilol
- Lead sponsor
- Takeshi Morimoto
Record details
- Record id
cardio:ct-nct01155635- Content hash
0cc2123482c2f9d52b32315ed30b310d9443d804e1f38798dd3504512b5e1aa5